High-dose melphalan with 6-hydroxydopamine–purged autologous bone marrow transplantation for poor-risk neuroblastoma
✍ Scribed by Brian H. Kushner; Jong-Hyo Kwon; Richard J. O'Reilly; Nai-Kong V. Cheung; Subhash C. Gulati; Philip R. Exelby
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 554 KB
- Volume
- 68
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Seven children with neuroblastoma who had relapsed on or after conventional therapy (3 originally stage IV, 3 stage III, 1 stage II) were entered on a study of "massive therapy" with purged autologous bone marrow rescue. In 5 patients attempts were made to reinduce remission with alternative chemoth
A Phase I or I1 trial was conducted to assess the toxicity and the efficacy of a tandem high dose chemotherapy combining ifosfamide, carboplatin, and teniposide in patients with poor prognosis ovarian carcinoma. ## METHODS. Thirtyseven patients were scheduled to receive tandem high dose therapy co